skip to main content

Chemistry, part 2

Content language

Contact us: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > quinazolines > n-[(cyclohexylamino)-oxomethyl]-2-[ethyl-[(4-oxo-1h-quinazolin-2-yl)methyl]amino]acetamide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > quinazolines > n-[(cyclohexylamino)-oxomethyl]-2-[ethyl-[(4-oxo-1h-quinazolin-2-yl)methyl]amino]acetamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > quinazolines > n-[(cyclohexylamino)-oxomethyl]-2-[ethyl-[(4-oxo-1h-quinazolin-2-yl)methyl]amino]acetamide
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > quinazolines > n-[(cyclohexylamino)-oxomethyl]-2-[ethyl-[(4-oxo-1h-quinazolin-2-yl)methyl]amino]acetamide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > quinazolines > n-[(cyclohexylamino)-oxomethyl]-2-[ethyl-[(4-oxo-1h-quinazolin-2-yl)methyl]amino]acetamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > quinazolines > n-[(cyclohexylamino)-oxomethyl]-2-[ethyl-[(4-oxo-1h-quinazolin-2-yl)methyl]amino]acetamide
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > quinazolines > n-[(cyclohexylamino)-oxomethyl]-2-[ethyl-[(4-oxo-1h-quinazolin-2-yl)methyl]amino]acetamide

Preferred term

n-[(cyclohexylamino)-oxomethyl]-2-[ethyl-[(4-oxo-1h-quinazolin-2-yl)methyl]amino]acetamide  

Type

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

Broader concept

charge

  • 0

formula

  • C20H27N5O3

inchi

  • InChI=1S/C20H27N5O3/c1-2-25(12-17-22-16-11-7-6-10-15(16)19(27)23-17)13-18(26)24-20(28)21-14-8-4-3-5-9-14/h6-7,10-11,14H,2-5,8-9,12-13H2,1H3,(H,22,23,27)(H2,21,24,26,28)

inchikey

  • ACABFUSMARNGNL-UHFFFAOYSA-N

mass

  • 385.461

monoisotopicmass

  • 385.21139

smiles

  • CCN(CC1=NC(=O)C2=CC=CC=C2N1)CC(=O)NC(=O)NC3CCCCC3

subset

  • 2_STAR

In other languages

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:111403

Download this concept:

RDF/XML TURTLE JSON-LD